Is Pre-emptive Genotyping Worth It?

KM

Kwame Mensah

Director of Health Economics, Meridian Life Sciences Society

Day 312:00 pm – 12:25 pmSeminar Room 2.2 (L2-SEM-2)
Part of: Pharmacogenomics at the Point of Prescribing (11:10 am – 12:25 pm)

Abstract

A cost-effectiveness model built from the programme’s own prescribing data.

Description

Presented in “Pharmacogenomics at the Point of Prescribing”.

About the Speaker

KM

Kwame Mensah

Director of Health Economics, Meridian Life Sciences Society

View Full Profile

Q&A for Is Pre-emptive Genotyping Worth It?

Sign in to vote on questions.

Details
Duration25 min
RoomSeminar Room 2.2 (L2-SEM-2)
Tags
#live-day#translational-medicine
This Session

Pharmacogenomics at the Point of Prescribing

11:10 am – 12:25 pm

Seminar Room 2.2

2 talks in this session

View Session
Other Talks in This Session
Decision Support That Prescribers Do Not Ignore

Liam O’Connell

11:35 am – 12:00 pm